Press release
Tendinitis Treatment Industry to Worth USD 13,099.0 million | Along with Eminent Players like Abbott, Pfizer, AstraZeneca, Bayer, Merck & others
Tendinitis Treatment - Market Scenario:
Tendinitis is a disease in which the tendons become inflamed. This disease is also known as tendonitis. Tendinitis can occur due to sports activities or activities like gardening, painting, scrubbing, carpentry, etc. It can also be caused due to calcium deposits near the tendons. Most commonly it is caused due to prolonged stress or subsequent wear and tear caused by repetitive movements.
Additionally, it can also be caused due to sudden trauma. Most people suffer from tendonitis while performing their daily jobs or enjoying hobbies or indulging in sports activities. Since, tendons become less flexible as the age increases, tendonitis can also be developed with age. Symptoms of tendinitis include pain, swelling, stiffness, and restricted mobility at the affected joint, muscle weakness and affected skin can feel warm over the surface. Anyone can suffer from this condition but the people above the age of 40 are more likely to suffer from Tendinitis.
Request for sample Report at https://www.marketresearchfuture.com/sample_request/5227
Tendinitis can occur in any part of the body. Most common areas can be knees, elbows, shoulders, hips, base of the thumb and Achilles tendon. When a person suffers from Tendinitis, he/she faces rising pain and/or frozen shoulder. It can be treated using physiotherapy, corticosteroid injections and surgery. In addition to this, tendinitis can be treated by rest, and OTC (Over the Counter) pain relieving medicines. The condition can be diagnosed directly through the physical exam.
Increasing cases of sports injuries, growing geriatric population, increasing cases of people suffering from diabetes and rheumatoid arthritis are the factors expected to drive the Tendinitis treatment market in Americas and Europe. According to a report published by the American Academy of Physical Medicine and Rehabilitation in 2014, 25 to 50% cases of sport injuries in the US are due to overuse of hand and wrist. Side effects of the treatment are likely to restrain the market. For instance, use of NSAIDs (Non-Steroidal Inflammatory Drugs) resulting in stomachache and gastrointestinal bleeding.
The market in Americas & Europe is expected to grow at a CAGR of 7.2% during the forecast period of 2017 to 2023 and estimated to reach at USD 13,099.0 million by 2023 from USD 7,525.3 in 2016.
Tendinitis Treatment Market – Competitive Landscape
The global tendinitis treatment market is observed to be growing rapidly owing to increasing developments of key players like Pfizer Inc., Abbott, AstraZeneca, Bayer AG, Merck & Co. Inc., GlaxoSmithKline plc, Teva Pharmaceuticals Industries Ltd. and Boehringer Ingelheim Pharmaceuticals Inc. which boosts the market growth.
Check Discount Here at https://www.marketresearchfuture.com/check-discount/5227
The key players in the market have adopted strategy to sustain its position in the global market through use of advanced technology to develop drugs for the treatment of Tendinitis.
In May 2017, Pfizer announced US FDA filing acceptance of supplemental new drug application (NDA) for Xeljanz for the treatment of patients suffering with active psoriatic arthritis, a chronic inflammatory multisystem disease caused due to various reasons including persistent painful tendonitis.
In August 2016, Teva Pharmaceuticals Industries Ltd. acquired Actavis Generics. This acquisition made Teva’s Generics and specialty business stronger.
Regional Analysis:
The American region is expected to be the leading region in the tendinitis treatment market due to the rising demand for new treatment options for tendinitis and rising cases of sport injuries and ailments such as arthritis. On regional basis, American region is divided into North America and South America. North America is expected to dominate the market due to presence of developed countries like the US and Canada. Additionally, development of sports medicines in the less developed and developed regions of America is boosting this market. According to the Center for Disease Control and Prevention, 26% people in the US aged more than 18 years will have medically diagnosed arthritis by 2040. Also, Tendinitis cases among the athletes in US have been increasing in the past few years which is likely to contribute to the market growth.
Europe is anticipated to be the second leading market for tendinitis treatment due to increasing prevalence of diabetes and rheumatoid arthritis. Availability of funds for R&D activities in medical devices will boost the demand for technologically advanced devices that help in the diagnosis of tendinitis. Lifestyle changes and minimal physical activity is boosting the growth of this market. European market is divided into two segments – Western Europe and Eastern Europe. Western Europe is expected to hold the largest market share in the European region. Within Western Europe, Germany is anticipated to lead the market due to innovative product development and rapid adoption of new treatments.
Ask Any Question at https://www.marketresearchfuture.com/enquiry/5227
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Tendinitis is a disease in which the tendons become inflamed. This disease is also known as tendonitis. Tendinitis can occur due to sports activities or activities like gardening, painting, scrubbing, carpentry, etc. It can also be caused due to calcium deposits near the tendons. Most commonly it is caused due to prolonged stress or subsequent wear and tear caused by repetitive movements.
Additionally, it can also be caused due to sudden trauma. Most people suffer from tendonitis while performing their daily jobs or enjoying hobbies or indulging in sports activities. Since, tendons become less flexible as the age increases, tendonitis can also be developed with age. Symptoms of tendinitis include pain, swelling, stiffness, and restricted mobility at the affected joint, muscle weakness and affected skin can feel warm over the surface. Anyone can suffer from this condition but the people above the age of 40 are more likely to suffer from Tendinitis.
Request for sample Report at https://www.marketresearchfuture.com/sample_request/5227
Tendinitis can occur in any part of the body. Most common areas can be knees, elbows, shoulders, hips, base of the thumb and Achilles tendon. When a person suffers from Tendinitis, he/she faces rising pain and/or frozen shoulder. It can be treated using physiotherapy, corticosteroid injections and surgery. In addition to this, tendinitis can be treated by rest, and OTC (Over the Counter) pain relieving medicines. The condition can be diagnosed directly through the physical exam.
Increasing cases of sports injuries, growing geriatric population, increasing cases of people suffering from diabetes and rheumatoid arthritis are the factors expected to drive the Tendinitis treatment market in Americas and Europe. According to a report published by the American Academy of Physical Medicine and Rehabilitation in 2014, 25 to 50% cases of sport injuries in the US are due to overuse of hand and wrist. Side effects of the treatment are likely to restrain the market. For instance, use of NSAIDs (Non-Steroidal Inflammatory Drugs) resulting in stomachache and gastrointestinal bleeding.
The market in Americas & Europe is expected to grow at a CAGR of 7.2% during the forecast period of 2017 to 2023 and estimated to reach at USD 13,099.0 million by 2023 from USD 7,525.3 in 2016.
Tendinitis Treatment Market – Competitive Landscape
The global tendinitis treatment market is observed to be growing rapidly owing to increasing developments of key players like Pfizer Inc., Abbott, AstraZeneca, Bayer AG, Merck & Co. Inc., GlaxoSmithKline plc, Teva Pharmaceuticals Industries Ltd. and Boehringer Ingelheim Pharmaceuticals Inc. which boosts the market growth.
Check Discount Here at https://www.marketresearchfuture.com/check-discount/5227
The key players in the market have adopted strategy to sustain its position in the global market through use of advanced technology to develop drugs for the treatment of Tendinitis.
In May 2017, Pfizer announced US FDA filing acceptance of supplemental new drug application (NDA) for Xeljanz for the treatment of patients suffering with active psoriatic arthritis, a chronic inflammatory multisystem disease caused due to various reasons including persistent painful tendonitis.
In August 2016, Teva Pharmaceuticals Industries Ltd. acquired Actavis Generics. This acquisition made Teva’s Generics and specialty business stronger.
Regional Analysis:
The American region is expected to be the leading region in the tendinitis treatment market due to the rising demand for new treatment options for tendinitis and rising cases of sport injuries and ailments such as arthritis. On regional basis, American region is divided into North America and South America. North America is expected to dominate the market due to presence of developed countries like the US and Canada. Additionally, development of sports medicines in the less developed and developed regions of America is boosting this market. According to the Center for Disease Control and Prevention, 26% people in the US aged more than 18 years will have medically diagnosed arthritis by 2040. Also, Tendinitis cases among the athletes in US have been increasing in the past few years which is likely to contribute to the market growth.
Europe is anticipated to be the second leading market for tendinitis treatment due to increasing prevalence of diabetes and rheumatoid arthritis. Availability of funds for R&D activities in medical devices will boost the demand for technologically advanced devices that help in the diagnosis of tendinitis. Lifestyle changes and minimal physical activity is boosting the growth of this market. European market is divided into two segments – Western Europe and Eastern Europe. Western Europe is expected to hold the largest market share in the European region. Within Western Europe, Germany is anticipated to lead the market due to innovative product development and rapid adoption of new treatments.
Ask Any Question at https://www.marketresearchfuture.com/enquiry/5227
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
